PNEUMONIA - BACTERIAL
Clinical trials for PNEUMONIA - BACTERIAL explained in plain language.
Never miss a new study
Get alerted when new PNEUMONIA - BACTERIAL trials appear
Sign up with your email to follow new studies for PNEUMONIA - BACTERIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pneumonia vaccine candidate enters early human testing
⭐️ VACCINE ⭐️ OngoingThis early-stage trial tests a new pneumococcal vaccine called PnMAPS30plus in 121 healthy adults aged 50 to 64. Participants receive a single shot of either the new vaccine or an approved one (PCV20) and are monitored for about six months. The goal is to check safety and whether…
Matched conditions: PNEUMONIA - BACTERIAL
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:38 UTC
-
New Toxin-Neutralizing drug could speed recovery from severe pneumonia
Disease control OngoingThis study tests whether adding CAL02 to standard antibiotics helps people with severe community-acquired bacterial pneumonia recover faster. CAL02 is designed to neutralize toxins released by bacteria. About 276 hospitalized adults in critical care will receive either CAL02 or a…
Matched conditions: PNEUMONIA - BACTERIAL
Phase: PHASE2 • Sponsor: Eagle Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hospital program aims to cut unnecessary antibiotics for kids
Knowledge-focused OngoingThis study tests a 'discharge stewardship bundle' to help doctors prescribe the right antibiotics for the right duration when children leave the hospital. Over 1,100 children with pneumonia, urinary tract infections, or skin infections will be followed. Doctors receive feedback r…
Matched conditions: PNEUMONIA - BACTERIAL
Phase: NA • Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC